A novel BRD4-NUT fusion in an undifferentiated sinonasal tumor highlights alternative splicing as a contributing oncogenic factor in NUT midline carcinoma.

Stirnweiss, A; McCarthy, K; Oommen, J; Crook, M L; Hardy, K; Kees, U R; Wilton, S D; Anazodo, A; Beesley, A H

Stirnweiss, A; McCarthy, K; Oommen, J; Crook, M L; Hardy, K; Kees, U R; Wilton, S D; Anazodo, A; Beesley, A H.

Affiliation

Stirnweiss A; Division of Children's Leukaemia and Cancer Research, Telethon Kids Institute, The University of Western Australia, West Perth, WA, Australia.
McCarthy K; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.
Oommen J; Division of Children's Leukaemia and Cancer Research, Telethon Kids Institute, The University of Western Australia, West Perth, WA, Australia.
Crook ML; Department of Pathology, Princess Margaret Hospital for Children, Perth, WA, Australia.
Hardy K; Cyto Labs Pty Ltd, Perth, WA, Australia.
Kees UR; Division of Children's Leukaemia and Cancer Research, Telethon Kids Institute, The University of Western Australia, West Perth, WA, Australia.
Wilton SD; Molecular Therapy Laboratory, Western Australian Neuroscience Research Institute, Centre for Comparative Genomics, Murdoch University, Perth, WA, Australia.
Anazodo A; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.
Beesley AH; Prince of Wales Hospital, Randwick, NSW, Australia.

Oncogenesis ; 4: e174, 2015 Nov 09.

Article in En | MEDLINE | ID: mdl-26551281

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Oncogenesis Year: 2015 Document type: Article Affiliation country: Australia Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google